Myelodysplastic Syndromes Clinical Trials in Chicago

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Recruiting
  • Myelodysplastic Syndromes
  • Birmingham, Alabama
  • +131 more
2021-11-22
Nov 22, 2021
O
Terminated
  • Hematopoietic Stem Cell Transplantation
  • +4 more
  • Duarte, California
  • +3 more
2021-11-10
Nov 10, 2021
G
Completed
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +5 more
2021-10-04
Oct 4, 2021
O
Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • TregGraft (Orca-T)
  • Duarte, California
  • +13 more
2021-10-28
Oct 28, 2021
S
Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +12 more
2021-10-29
Oct 29, 2021
C
H
Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • Stanford, California
  • +26 more
2021-10-06
Oct 6, 2021
A
Recruiting
  • Myelodysplastic Syndromes
  • ASTX727 LD
  • ASTX727 SD
  • Anniston, Alabama
  • +25 more
2021-09-21
Sep 21, 2021
N
Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
2021-09-03
Sep 3, 2021
A
Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
2021-09-01
Sep 1, 2021
A
Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +22 more
2021-08-17
Aug 17, 2021
I
Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
2021-08-17
Aug 17, 2021
O
Recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
  • Los Angeles, California
  • +17 more
2021-07-27
Jul 27, 2021
M
Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CliniMacs TCR alpha-beta-Biotin system
  • Los Angeles, California
  • +9 more
2021-07-27
Jul 27, 2021
M
Active, not recruiting
  • Hematopoietic Stem Cell Transplantation
  • +4 more
  • Duarte, California
  • +3 more
2021-07-19
Jul 19, 2021
U
Recruiting
  • Classical Hodgkin Lymphoma
  • +3 more
  • Chicago, Illinois
    University of Chicago
2021-06-29
Jun 29, 2021
O
Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
2021-06-15
Jun 15, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Chicago, Illinois
    University of Illinois at Chicago
2021-05-26
May 26, 2021
C
Active, not recruiting
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +58 more
2021-05-04
May 4, 2021
R
Unknown status
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
2021-04-20
Apr 20, 2021